MedPath

苏州盛迪亚生物医药有限公司

Ownership
-
Established
2015-09-01
Employees
-
Market Cap
-
Website
http://172.29.100.10:8000

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

NMPA:5

Drug Approvals

Trastuzumab rezetecan for Injection

Product Name
艾维达
Approval Number
国药准字S20250024
Approval Date
May 27, 2025
NMPA

Vunakizumab Injection

Product Name
安达静
Approval Number
国药准字S20240049
Approval Date
Oct 22, 2024
NMPA

Vunakizumab Injection

Product Name
安达静
Approval Number
国药准字S20240037
Approval Date
Aug 20, 2024
NMPA

Bevacizumab Injection

Product Name
艾瑞妥
Approval Number
国药准字S20210020
Approval Date
Jun 22, 2021
NMPA

Camrelizumab for Injection

Product Name
艾瑞卡
Approval Number
国药准字S20190027
Approval Date
May 29, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.